326 related articles for article (PubMed ID: 32374852)
1. Mature Imaging-Based Outcomes Supporting Local Control for Complex Reirradiation Salvage Spine Stereotactic Body Radiotherapy.
Detsky JS; Nguyen TK; Lee Y; Atenafu E; Maralani P; Husain Z; Tseng CL; Myrehaug S; Soliman H; Sahgal A
Neurosurgery; 2020 Sep; 87(4):816-822. PubMed ID: 32374852
[TBL] [Abstract][Full Text] [Related]
2. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
3. Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiation Therapy With Conventional Palliative External Beam Radiation Therapy.
Zeng KL; Myrehaug S; Soliman H; Husain ZA; Tseng CL; Detsky J; Ruschin M; Atenafu EG; Witiw CD; Larouche J; da Costa L; Maralani PJ; Parulekar WR; Sahgal A
Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):293-300. PubMed ID: 35675854
[TBL] [Abstract][Full Text] [Related]
4. Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases.
Thibault I; Campbell M; Tseng CL; Atenafu EG; Letourneau D; Yu E; Cho BC; Lee YK; Fehlings MG; Sahgal A
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):353-60. PubMed ID: 26383680
[TBL] [Abstract][Full Text] [Related]
5. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review.
Myrehaug S; Sahgal A; Hayashi M; Levivier M; Ma L; Martinez R; Paddick I; Régis J; Ryu S; Slotman B; De Salles A
J Neurosurg Spine; 2017 Oct; 27(4):428-435. PubMed ID: 28708043
[TBL] [Abstract][Full Text] [Related]
6. Re-irradiation of Vertebral Body Metastases: Treatment in the Radiosurgery Era.
Myrehaug S; Soliman H; Tseng C; Heyn C; Sahgal A
Clin Oncol (R Coll Radiol); 2018 Feb; 30(2):85-92. PubMed ID: 29203091
[TBL] [Abstract][Full Text] [Related]
7. Postoperative re-irradiation using stereotactic body radiotherapy for metastatic epidural spinal cord compression.
Ito K; Nihei K; Shimizuguchi T; Ogawa H; Furuya T; Sugita S; Hozumi T; ; Karasawa K
J Neurosurg Spine; 2018 Sep; 29(3):332-338. PubMed ID: 29905524
[TBL] [Abstract][Full Text] [Related]
8. Strategies to Mitigate Toxicities From Stereotactic Body Radiation Therapy for Spine Metastases.
Schaub SK; Tseng YD; Chang EL; Sahgal A; Saigal R; Hofstetter CP; Foote M; Ko AL; Yuh WTC; Mossa-Basha M; Mayr NA; Lo SS
Neurosurgery; 2019 Dec; 85(6):729-740. PubMed ID: 31264703
[TBL] [Abstract][Full Text] [Related]
9. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.
Thibault I; Al-Omair A; Masucci GL; Masson-Côté L; Lochray F; Korol R; Cheng L; Xu W; Yee A; Fehlings MG; Bjarnason GA; Sahgal A
J Neurosurg Spine; 2014 Nov; 21(5):711-8. PubMed ID: 25170656
[TBL] [Abstract][Full Text] [Related]
10. Imaging-Based Outcomes for 24 Gy in 2 Daily Fractions for Patients with de Novo Spinal Metastases Treated With Spine Stereotactic Body Radiation Therapy (SBRT).
Tseng CL; Soliman H; Myrehaug S; Lee YK; Ruschin M; Atenafu EG; Campbell M; Maralani P; Yang V; Yee A; Sahgal A
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):499-507. PubMed ID: 30003994
[TBL] [Abstract][Full Text] [Related]
11. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
[TBL] [Abstract][Full Text] [Related]
12. Local control and patterns of failure for "Radioresistant" spinal metastases following stereotactic body radiotherapy compared to a "Radiosensitive" reference.
Zeng KL; Sahgal A; Husain ZA; Myrehaug S; Tseng CL; Detsky J; Sarfehnia A; Ruschin M; Campbell M; Foster M; Das S; Lipsman N; Bjarnason GA; Atenafu EG; Maralani PJ; Soliman H
J Neurooncol; 2021 Mar; 152(1):173-182. PubMed ID: 33453002
[TBL] [Abstract][Full Text] [Related]
13. Histopathological Findings After Reirradiation Compared to First Irradiation of Spinal Bone Metastases With Stereotactic Body Radiotherapy: A Cohort Study.
Foerster R; Cho BCJ; Fahim DK; Gerszten PC; Flickinger JC; Grills IS; Jawad MS; Kersh CR; Létourneau D; Mantel F; Sahgal A; Shin JH; Winey BA; Guckenberger M
Neurosurgery; 2019 Feb; 84(2):435-441. PubMed ID: 29547929
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases.
Sahgal A; Ames C; Chou D; Ma L; Huang K; Xu W; Chin C; Weinberg V; Chuang C; Weinstein P; Larson DA
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):723-31. PubMed ID: 19095374
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy for spine metastases: a review of 24 Gy in 2 daily fractions.
Nguyen EK; Ruschin M; Zhang B; Soliman H; Myrehaug S; Detsky J; Chen H; Sahgal A; Tseng CL
J Neurooncol; 2023 May; 163(1):15-27. PubMed ID: 37155133
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic Body Radiation Therapy for Spinal Metastases: Benefits and Limitations.
Guckenberger M; Dahele M; Ong WL; Sahgal A
Semin Radiat Oncol; 2023 Apr; 33(2):159-171. PubMed ID: 36990633
[TBL] [Abstract][Full Text] [Related]
18. Reirradiation of the spine with stereotactic radiosurgery: Efficacy and toxicity.
Boyce-Fappiano D; Elibe E; Zhao B; Siddiqui MS; Lee I; Rock J; Ryu S; Siddiqui F
Pract Radiat Oncol; 2017; 7(6):e409-e417. PubMed ID: 28673511
[TBL] [Abstract][Full Text] [Related]
19. Marginal recurrence requiring salvage radiotherapy after stereotactic body radiotherapy for spinal metastases.
Koyfman SA; Djemil T; Burdick MJ; Woody N; Balagamwala EH; Reddy CA; Angelov L; Suh JH; Chao ST
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):297-302. PubMed ID: 21985940
[TBL] [Abstract][Full Text] [Related]
20. Utility of molecular markers in predicting local control specific to lung cancer spine metastases treated with stereotactic body radiotherapy.
Shor D; Louie AV; Zeng KL; Menjak IB; Atenafu EG; Chia-Lin Tseng ; Detsky J; Larouche J; Zhang B; Soliman H; Myrehaug S; Maralani P; Hwang DM; Sahgal A; Chen H
J Neurooncol; 2024 Apr; 167(2):275-283. PubMed ID: 38526757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
